Company: SHPH
Filing Date: 2025-03-31
Form Type: DEF 14A
Source: 0001641172-25-001889
Chunk: 27

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-03-31
Form: DEF 14A
Chunk 27
---
 addition, we will not issue fractional shares in connection with the Reverse Stock Split, and stockholders who would have otherwise been entitled to receive such fractional shares will receive an amount in cash determined in the manner set forth below under the heading “Fractional Shares.”

Following the effectiveness of the Reverse Stock Split, if approved by the stockholders and implemented by the Company, current stockholders will hold fewer shares of common stock.

Board of Directors’ Discretion to Implement the Reverse Stock Split

The Board of Directors believes that stockholder approval of a range of ratios (as opposed to a single reverse stock split ratio) is in the best interests of the Company and stockholders because it is not possible to predict market conditions at the time that the Reverse Stock Split would be effected. We believe that a range of Reverse Stock Split ratios provides us with the most flexibility to achieve the desired results of the Reverse Stock Split. The Reverse Stock Split Ratio to be selected by our Board of Directors, or a special committee designated by our Board of Directors, will be a whole number in a range of 1-for-3 to 1-for-8. The Board of Directors also has the authority to abandon the Reverse Stock Split amendment.

In determining the final ratio and whether and when to effect the Reverse Stock Split following the receipt of stockholder approval, the Board of Directors will consider a number of factors, including, without limitation:

| ● | our                                                                                                                               
 ability to maintain the listing of our common stock on Nasdaq;                                                                    |
| ● | the                                                                                                                               
 historical trading price and trading volume of our common stock;                                                                  |
| ● | the                                                                                                                               
 number of shares of our common stock outstanding immediately before and after the Reverse Stock Split;                            |
| ● | the                                                                                                                               
 dilutive impact of any potential exercise of the Company’s outstanding warrants to purchase common stock and the related impact   
 on the trading price of our common stock;                                                                                         |
| ● | the                                                                                                                               
 then-prevailing trading price and trading volume of our common stock and the anticipated impact of the Reverse Stock Split on the 
 trading price and trading volume of our common stock;                                                                             |
| ● | the                                                                                                                               
 anticipated impact of a particular ratio on the number of holders of our common stock; and                                        |
| ● | prevailing                                                                                                                        
 general market conditions.                                                                                                        |

We believe that granting the Board of Directors the authority to set the ratio for the Reverse Stock Split is essential because it allows us to take these factors into consideration and to react to changing market conditions.